tiprankstipranks
Advertisement
Advertisement
Abeona Therapeutics reports 2025 EPS $1.01 vs. ($1.55) last year
PremiumThe FlyAbeona Therapeutics reports 2025 EPS $1.01 vs. ($1.55) last year
12d ago
Options Volatility and Implied Earnings Moves This Week, March 16 – March 20, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, March 16 – March 20, 2026
13d ago
ABEO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ABEO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
14d ago
Abeona Therapeutics: Advancing UX111 Toward First-to-Market Approval and Scaling ZEVASKYN Launch to Near-Term Profitability
PremiumRatingsAbeona Therapeutics: Advancing UX111 Toward First-to-Market Approval and Scaling ZEVASKYN Launch to Near-Term Profitability
2M ago
Aehr, Fastenal, Regions, Abeona, Taysha: Insider Firestorm
Premium
Weekend Updates
Aehr, Fastenal, Regions, Abeona, Taysha: Insider Firestorm
2M ago
Dave & Buster’s, American Eagle, Cabaletta, Abeona, Oncolytics Insider Shock
Premium
Weekend Updates
Dave & Buster’s, American Eagle, Cabaletta, Abeona, Oncolytics Insider Shock
2M ago
Abeona Therapeutics: Promising Growth with ZEVASKYN’s Market Expansion and Strategic Advancements
PremiumRatingsAbeona Therapeutics: Promising Growth with ZEVASKYN’s Market Expansion and Strategic Advancements
4M ago
Abeona Therapeutics announces first patient treatment with ZEVASKYN
Premium
The Fly
Abeona Therapeutics announces first patient treatment with ZEVASKYN
4M ago
Abeona Therapeutics reports employee inducement grants
Premium
The Fly
Abeona Therapeutics reports employee inducement grants
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100